Evaluation of nanoparticles as oral vehicles for immunotherapy against experimental peanut allergy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Biological Macromolecules

• Publication date

  2017-09-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijbiomac.2017.09.109PMID 28965967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allergen immunotherapy for IgE‐mediated food allergy: a systematic review and meta‐analysis

  2017cited by this paper
• Use of biologics in severe food allergies

  2017cited by this paper
• Mucoadhesive vs. mucopenetrating particulate drug delivery.

  2016cited by this paper
• Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens

  2015cited by this paper
• In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.

  2015cited by this paper
• Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.

  2015cited by this paper
• Food Allergies: The Basics

  2015cited by this paper
• Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.

  2015cited by this paper
• A novel rapid (20-minute) IL-6 release assay using blood mononuclear cells of patients with various clinical forms of drug induced skin injuries

  2015cited by this paper
• Methods to determine the interactions of micro- and nanoparticles with mucus.

  2015cited by this paper
• Innate and adaptive immune functions of peyer's patch monocyte-derived cells.

  2015cited by this paper
• Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications

  2014cited by this paper
• Delineating the Role of Histamine-1- and -4-Receptors in a Mouse Model of Th2-Dependent Antigen-Specific Skin Inflammation

  2014cited by this paper
• The Molecular Basis of Peanut Allergy

  2014cited by this paper
• Nanoparticle based-immunotherapy against allergy.

  2014cited by this paper
• Immunogenicity of Peanut Proteins Containing Poly(Anhydride) Nanoparticles

  2014cited by this paper
• Comparison of adrenaline auto‐injector devices: Ease of use and ability to recall use

  2014cited by this paper
• Ionic complexation as a non-covalent approach for the design of folate anchored rifampicin Gantrez nanoparticles.

  2013cited by this paper
• Prophylaxis of intranasally induced pollen allergy in a BALB/C mouse model using a potential prebiotic β-1, 4 mannobiose.

  2013cited by this paper
• Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN).

  2012cited by this paper
• Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice.

  2012cited by this paper
• Development of poly(anhydride) nanoparticles loaded with peanut proteins: the influence of preparation method on the immunogenic properties.

  2012cited by this paper
• Peyer's Patches: The Immune Sensors of the Intestine

  2010cited by this paper
• Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation

  2010cited by this paper
• Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression.

  2010cited by this paper
• Is oral immunotherapy the cure for food allergies?

  2010cited by this paper
• Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life.

  2008cited by this paper
• Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis.

  2008cited by this paper
• Original article: Prevalence and cumulative incidence of food hypersensitivity in the first 3years of life

  2008cited by this paper
• Initiating mechanisms of food allergy: Oral tolerance versus allergic sensitization.

  2007cited by this paper
• Prevalence of Sensitization to Food Allergens Among Food Allergy Index and Control Families

  2007cited by this paper
• Allergen immunotherapy: a practice parameter third update.

  2007cited by this paper
• IgE-mediated food allergy diagnosis: Current status and new perspectives.

  2007cited by this paper
• Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

  2006cited by this paper
• Prevalence of sensitization to food allergens, reported adverse reaction to foods, food avoidance, and food hypersensitivity among teenagers.

  2005cited by this paper
• Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

  2004cited by this paper
• Functional CD25– and CD25+ mucosal regulatory T cells are induced in gut‐draining lymphoid tissue within 48 h after oral antigen application

  2003cited by this paper
• Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates.

  2002cited by this paper
• How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland

  2002cited by this paper
• Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles.

  2002cited by this paper
• Food allergy

  2002cited by this paper
• Diffusion of macromolecules and virus-like particles in human cervical mucus.

  2001cited by this paper
• Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

  1999cited by this paper
• Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the beta-chymase, mouse mast cell protease-1.

  1998cited by this paper
• Constitutive expression of mouse mast cell protease‐1 in normal BALB/c mice and its up‐regulation during intestinal nematode infection

  1997cited by this paper

• Novel zwitterionic densely charged neutral sulfobetaine polymeric micelles for oral delivery of therapeutic peptides: a proof-of-concept study

  2025cites this paper
• Emerging nanotherapeutic strategies targeting gut-X axis against diseases.

  2023cites this paper
• Treatment of food allergy: oral immunotherapy, biologics and beyond.

  2023cites this paper
• Future of Nanotechnology in Food Industry: Challenges in Processing, Packaging, and Food Safety

  2023cites this paper
• Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate

  2022cites this paper
• Biotechnological advancements towards water, food and medical healthcare: A review.

  2022cites this paper
• Nanosystems as curative platforms for allergic disorder management.

  2021cites this paper
• Quantifying the effects of antibiotic treatment on the extracellular polymer network of antimicrobial resistant and sensitive biofilms using multiple particle tracking

  2021cites this paper
• Role of nanostructures in allergy: Diagnostics, treatments and safety

  2021cites this paper
• New Insights in Therapy for Food Allergy

  2021cites this paper
• Nanoparticles in allergen immunotherapy

  2021cites this paper
• Nanotechnology and biomaterials for immune modulation and monitoring

  2021cites this paper
• Targeting the Gut Mucosal Immune System Using Nanomaterials

  2021cites this paper
• Advancements in nanotechnology for food science and industry

  2021cites this paper
• Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon

  2020cites this paper
• Allergen Immunotherapy in Children User’s Guide

  2020cites this paper
• Optimising the use of proteins from rich meat co-products and non-meat alternatives: Nutritional, technological and allergenicity challenges.

  2020cites this paper
• Nanoparticle-based immunotherapy: state of the art and future perspectives

  2020cites this paper
• Role of nanostructures in allergy: adverse effects, diagnostics, and treatment

  2020cites this paper
• An Overview of the Applications of Nanomaterials and Nanodevices in the Food Industry

  2020cites this paper
• The Nano-Intestine Interaction: Understanding the Location-Oriented Effects of Engineered Nanomaterials in the Intestine.

  2020cites this paper
• EAACI Allergen Immunotherapy User's Guide

  2020cites this paper
• Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy.

  2019cites this paper
• Oral Immunogenicity in Mice and Sows of Enterotoxigenic Escherichia Coli Outer-Membrane Vesicles Incorporated into Zein-Based Nanoparticles

  2019cites this paper
• Utility of Nanomaterials in Food Safety

  2019cites this paper
• Prospects of using nanotechnology for food preservation, safety, and security

  2018cites this paper
• Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape

  2018cites this paper